SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 53 filers reported holding SIGILON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $89,753 | +213597.6% | 96,499 | -21.4% | 0.00% | – |
| Q4 2022 | $42 | -99.9% | 122,799 | +0.3% | 0.00% | – |
| Q3 2022 | $61,000 | -39.0% | 122,379 | +0.9% | 0.00% | – |
| Q2 2022 | $100,000 | -72.5% | 121,245 | -50.9% | 0.00% | – |
| Q1 2022 | $363,000 | -43.8% | 247,177 | +5.6% | 0.00% | – |
| Q4 2021 | $646,000 | -50.6% | 234,153 | +1.1% | 0.00% | – |
| Q3 2021 | $1,308,000 | -8.9% | 231,662 | +73.2% | 0.00% | – |
| Q2 2021 | $1,435,000 | -47.3% | 133,775 | +9.7% | 0.00% | – |
| Q1 2021 | $2,725,000 | +235.2% | 121,940 | +620.3% | 0.00% | – |
| Q4 2020 | $813,000 | – | 16,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|